A number of other research analysts have also commented on IPHS. TheStreet lowered shares of Innophos from a b- rating to a c+ rating in a research note on Thursday, May 23rd. Zacks Investment Research lowered shares of Innophos from a hold rating to a sell rating in a research note on Friday, August 9th. Two equities research analysts have rated the stock with a sell rating, one has assigned a hold rating and one has issued a buy rating to the stock. The stock has an average rating of Hold and an average price target of $31.00.
Shares of IPHS stock opened at $28.36 on Friday. The company has a current ratio of 2.85, a quick ratio of 1.41 and a debt-to-equity ratio of 0.97. Innophos has a 1 year low of $22.57 and a 1 year high of $46.65. The firm’s fifty day moving average price is $27.28 and its two-hundred day moving average price is $29.44. The firm has a market capitalization of $558.41 million, a P/E ratio of 12.44 and a beta of 1.43.
Innophos (NASDAQ:IPHS) last released its quarterly earnings data on Tuesday, August 6th. The specialty chemicals company reported $0.43 earnings per share for the quarter, topping the consensus estimate of $0.37 by $0.06. The company had revenue of $185.04 million for the quarter, compared to analyst estimates of $196.55 million. Innophos had a net margin of 3.79% and a return on equity of 12.35%. Innophos’s revenue for the quarter was down 10.5% compared to the same quarter last year. During the same period in the previous year, the business earned $0.55 EPS. As a group, equities research analysts forecast that Innophos will post 2.18 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which was paid on Friday, September 6th. Shareholders of record on Friday, August 23rd were given a $0.48 dividend. This represents a $1.92 annualized dividend and a yield of 6.77%. The ex-dividend date of this dividend was Thursday, August 22nd. Innophos’s dividend payout ratio (DPR) is currently 84.21%.
Hedge funds and other institutional investors have recently made changes to their positions in the business. BlackRock Inc. boosted its stake in Innophos by 0.7% during the second quarter. BlackRock Inc. now owns 2,971,609 shares of the specialty chemicals company’s stock worth $86,504,000 after acquiring an additional 20,096 shares in the last quarter. Vanguard Group Inc. lifted its stake in shares of Innophos by 2.0% in the second quarter. Vanguard Group Inc. now owns 2,160,323 shares of the specialty chemicals company’s stock valued at $62,887,000 after buying an additional 42,356 shares in the last quarter. Dimensional Fund Advisors LP lifted its stake in shares of Innophos by 3.7% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,084,227 shares of the specialty chemicals company’s stock valued at $26,596,000 after buying an additional 38,309 shares in the last quarter. Renaissance Technologies LLC lifted its stake in shares of Innophos by 14.8% in the second quarter. Renaissance Technologies LLC now owns 867,700 shares of the specialty chemicals company’s stock valued at $25,259,000 after buying an additional 111,900 shares in the last quarter. Finally, Investment Counselors of Maryland LLC lifted its stake in shares of Innophos by 1.1% in the second quarter. Investment Counselors of Maryland LLC now owns 605,945 shares of the specialty chemicals company’s stock valued at $17,639,000 after buying an additional 6,814 shares in the last quarter. Hedge funds and other institutional investors own 96.02% of the company’s stock.
Innophos Holdings, Inc, together with its subsidiaries, produces specialty ingredients with applications in food, health, nutrition, and industrial markets. It operates through three segments: Food, Health and Nutrition; Industrial Specialties; and Other. The company’s specialty ingredients include specialty phosphate salts and specialty phosphoric acids, as well as other mineral, enzyme, and botanical based specialty ingredients that are used as flavor enhancers in beverages; electrolytes in sports drinks; texture modifiers in cheeses; leavening agents in baked goods; calcium and phosphorus fortification in food and beverages; moisture and color retention in seafood, poultry, and meat; excipients in vitamins, minerals, nutritional supplements, and pharmaceuticals; and abrasives in toothpaste.
Featured Story: Limitations to arbitrage trading
Receive News & Ratings for Innophos Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Innophos and related companies with MarketBeat.com’s FREE daily email newsletter.